JAK2 and non-small cell lung carcinoma: Importantly, STAT4 is predicted as a transcription factor for BARD1 in NSCLC cells by using the PROMO, and there is evidence that the expression of STAT4 was persistently activated in NSCLC cells through its co‐activator JAK2.42, 43